Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The stock market is crashing due to coronavirus worries, and the healthcare giant is getting caught in the undertow.

Why CVS Health Stock Is Tanking Today

Given the growing prospects of specialty pharmacy, CVS Health (CVS) is prioritizing expansion of this business.

CVS Health's Schnuck Pharmacy Buyout to Widen Specialty Arm

CVS Taking Over Grocery Chain's Pharmacies

CVS Health said it will buy the retail and specialty pharmacy business of Schnuck Markets Inc., a large Midwestern grocer with more than 100 stores.

CVS To Buy 110 Schnuck’s Grocer Pharmacies In The Midwest

Amazon

Costco

Walmart

What To Stock Up On For Coronavirus

Anthem

Cigna

UnitedHealth Group

Key developments by the U.S. government could have a profound impact on the country's health insurers.

Will Coronavirus Harm Health Insurers?

CVS Health Corp. CVS, +2.12% said Tuesday that it will acquire 110 Schnuck Markets Inc. pharmacies across the Midwest.

CVS Health acquires 110 Schnuck pharmacies in the Midwest

CVS Health Corp. CVS, -4.44% said Tuesday that it will acquire 110 Schnuck Markets Inc.

CVS Health acquires 110 Schuck Markets in the Midwest

Drugstore giant CVS Health said it will “waive charges for home delivery of prescription medications” as the elderly and others at high risk for complications from the Coronavirus strain COVID-19 are urged to stay in their homes.

CVS Waiving Home Delivery Prescription Fees Amid Coronavirus Precautions

With a growing incidence of chronic kidney diseases and end-stage renal failure in the United States, CVS Health's (CVS) new partnerships seem to be strategic.

CVS Health's Latest Alliances to Fortify Kidney-Care Business

Both of these stocks are good value buys that pay a dividend, but which one should investors choose today in light of the coronavirus market correction?

Better Buy:  CVS Health vs. Walmart

The healthcare conglomerate's response to the COVID-19 outbreak is good news for Aetna members worried about out-of-pocket costs.

Aetna Insurance Members to Receive COVID-19 Fighting Resources from CVS Health

CVS Health Corp. CVS, -2.54% said Friday it is providing Aetna members with COVID-19 diagnostic testing and telemedicine visits with no out-of-pocket costs.

CVS to offer Aetna members COVID-19 diagnostic testing with zero co-pay

Teladoc

Here are four telemedicine stocks which have robust prospects to become attractive picks on the COVID-19 economic doldrums.

Can Telemedicine be a Market Savior on Rising Corona Scare?

Bank of America

Bed Bath & Beyond

Best Buy

Ford Motor Company

Intel

AT&T

Underperforming value stocks over the past decade will outperform over the next decade

7  Strong Value Stocks  to Buy for 2020

Humana

Investors are responding enthusiastically to the changing dynamics in the Democratic presidential race.

Here's Why Big Health Insurance Stocks Are Soaring Today

Home Depot

Johnson & Johnson

Kroger

Procter & Gamble

Sturm, Ruger & Company

Vista Outdoor

With the coronavirus outbreak raging across the globe, many investors are running for cover. But these stocks to buy might perform well in March due to a broader consumer sentiment shift.

8 Stocks to Buy in March for a Coronavirus Rebound

At the most recent count as of the writing of this article on March 4, 2019, the novel coronavirus (Covid-19) has 93,000 confirmed cases in nearly 80 countries.

CVS Health Corp: A Solid Place to Hide in the Coronavirus Sell Off

CVS Health: A Solid Place to Hide in the Coronavirus Selloff

1Life Healthcare

These three companies could surge if the coronavirus continues to spread.

3 Healthcare Stocks to Own Before the Coronavirus Outbreak Gets Worse

Health care plan stocks may see heightened volatility as Super Tuesday unfolds. Explore ideas to trade three prominent industry players.

Health Care Plan Stocks in Focus as Super Tuesday Looms

Rite Aid

Target

These retail stocks popped following reports that foot traffic was strong this weekend in response to the COVID-19 outbreak.

Why Shares of Walmart, Target, CVS Health, and Rite Aid Jumped Today

Walgreens

Americans should stock up while they can before it's too late.

CVS and Walgreens Warn of Hand Sanitizer Shortage as Coronavirus Spreads

Crown Castle International

CyrusOne

Cisco Systems

CenturyLink

Digital Realty Trust

Kraft Heinz

Prudential Financial

Restaurant Brands

Regions Financial

Truist Financial

Vodafone Group

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Wells Fargo

Exxon Mobil

Dividend stocks are the first thing prudent investors should buy after the virus scare dissipates. Income names won't be discounted forever.

Dividend Stocks Are Screaming-Hot Buys Once Coronavirus Fears Fade

US drug stores, retailers and suppliers are racing to keep up with surging interest for cleaning products as fears over coronavirus intensify.

CVS and Walgreens warn there could be a shortage of hand sanitizer

News for CVS Health Stock (CVS)